CVE-2022-22380— IBM Security Verify Privilege improper authentication
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2022-22380
Vulnerability Information
Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗ Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.
Vulnerability Title
IBM Security Verify Privilege improper authentication
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM Security Verify Privilege On-Premises 11.5 could allow an attacker to spoof a trusted entity due to improperly validating certificates. IBM X-Force ID: 221957.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:L/I:L/A:L
Source: NVD (National Vulnerability Database)
Vulnerability Type
证书验证不恰当
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM Security Verify Privilege Manager 信任管理问题漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM Security Verify Privilege Manager是美国国际商业机器（IBM）公司的一个用于公司环境中用于端点特权管理和应用程序控制的安全管理软件。该软件通过从端点移除本地管理权限，阻止恶意软件和勒索软件的无意下载进而攻击应用程序，利用 IBM Security Privilege Manager，可立即轻松执行最小特权和应用程序控制。。 IBM Security Verify Privilege On-Premises 11.5 版本存在安全漏洞，该漏洞源于证书验证不正确，攻击者
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
| Vendor | Product | Affected Versions | CPE | Subscribe |
|---|---|---|---|---|
| IBM | Security Verify Privilege | 11.5 | - |
II. Public POCs for CVE-2022-22380
| # | POC Description | Source Link | Shenlong Link |
|---|
AI-Generated POCPremium
No public POC found.
Login to generate AI POCIII. Intelligence Information for CVE-2022-22380
请登录查看更多情报信息。
- https://www.ibm.com/support/pages/node/7047202vendor-advisory
- https://nvd.nist.gov/vuln/detail/CVE-2022-22380
Same Patch Batch · IBM · 2023-10-17 · 13 CVEs total
| CVE-2022-22375 | 7.2 HIGH | IBM Security Verify Privilege command execution |
| CVE-2021-29913 | 6.5 MEDIUM | IBM Security Verify Privilege improper input validation |
| CVE-2022-22385 | 5.9 MEDIUM | IBM Security Verify Privilege information disclosure |
| CVE-2022-43889 | 5.3 MEDIUM | IBM Security Verify Privilege information disclosure |
| CVE-2021-20581 | 5.3 MEDIUM | IBM Security Verify Privilege information disclosure |
| CVE-2022-22386 | 5.3 MEDIUM | IBM Security Verify Privilege information disclosure |
| CVE-2022-22377 | 5.3 MEDIUM | IBM Security Verify Privilege information disclosure |
| CVE-2021-38859 | 4.3 MEDIUM | IBM Security Verify Privilege information disclosure |
| CVE-2022-22384 | 4.3 MEDIUM | IBM Security Verify Privilege improper input validation |
| CVE-2022-43892 | 3.7 LOW | IBM Security Verify Privilege information disclosure |
| CVE-2022-43891 | 2.7 LOW | IBM Security Verify Privilege information disclosure |
| CVE-2022-43893 | 2.7 LOW | IBM Security Verify Privilege denial of service |
IV. Related Vulnerabilities
Same product: Security Verify Privilege
- CVE-2024-31887
IBM Security Verify Privilege information disclosure - CVE-2022-43891
IBM Security Verify Privilege information disclosure - CVE-2022-43892
IBM Security Verify Privilege information disclosure - CVE-2022-43893
IBM Security Verify Privilege denial of service - CVE-2022-43889
IBM Security Verify Privilege information disclosure
Same vendor: IBM
- CVE-2026-1577
IBM® Db2® is vulnerable to a denial of service with a specia - CVE-2025-36122
IBM® Db2® is vulnerable to a denial of service with a specia - CVE-2025-14688
IBM® Db2® is vulnerable to a denial of service when fetching - CVE-2026-2311
IBM i is affected by a privilege escalation vulnerability in - CVE-2025-36180
Inadequate Pod Communication Restrictions, affects watsonx.d
Same weakness: CWE-295
V. Comments for CVE-2022-22380
No comments yet